Shares of ScanSource (SCSC), Jabil (JBL), and Lumen (LUMN) all jumped significantly after Iran announced the reopening of the Strait of Hormuz. This news eased international tensions, boosting corporate IT spending outlooks and improving the macroeconomic climate for IT service providers. The increased investor confidence is driven by more predictable expenses for IT firms and a "risk-on" environment for growth-oriented assets.

Shares of Meritage Homes, Taylor Morrison Home, and PulteGroup surged after oil prices dropped following Iran's announcement of reopening the Strait of Hormuz. This reduction in energy costs benefits homebuilders by maintaining margins and allowing for more competitive pricing. The news also revived hopes for Federal Reserve interest rate adjustments and encouraged potential home buyers to re-enter the market, signaling resilient long-term housing demand.

The FDA has approved deucravacitinib (Sotyktu; Bristol Myers Squibb) for adults with active psoriatic arthritis (PsA), marking it as the first and only TYK2 inhibitor for this condition. This approval expands the drug's use, as it was previously authorized for moderate-to-severe plaque psoriasis. Clinical trials demonstrated significant improvement in symptoms and inhibition of radiographic progression, with a safety profile consistent with its prior use.

JetBlue Airways stock saw a 7.89% gain today, trading at $5.95 following the debut of new nonstop Boston-Barcelona flights, which expands its transatlantic network. Despite this growth, the airline faces significant financial challenges, including a potential bankruptcy warning from its founder by 2026 and a credit downgrade from Fitch due to liquidity concerns. Technically, the stock shows bullish momentum, but overbought indicators suggest a potential consolidation phase in the near term.

Jazz Pharmaceuticals PLC stock reached an all-time high of $202.58, marking a 96.99% increase over the past year and indicating strong investor confidence. The company demonstrated operational efficiency with a 91.67% gross profit margin and analysts project earnings of $25.59 per share for fiscal 2026. This milestone is further supported by recent strong financial results, including record revenue and successful product launches, leading to positive analyst ratings and price target increases.

West Pharmaceutical, a key supplier of advanced drug delivery systems, is strategically positioned to capitalize on the biotech boom and surging demand for specialized components. The company's proprietary technologies, strong regulatory compliance, and global footprint make it an attractive investment for those seeking exposure to healthcare innovation and defensive growth. While risks like supply chain disruptions and competition exist, West's leadership in high-value drug delivery and focus on innovation suggest sustained demand and potential for long-term shareholder value.

Salesforce Inc. is at a critical juncture where AI integration will define its future growth, and the company's ability to monetize AI will be a key determinant of its success. As a leading provider of cloud-based CRM software, Salesforce is leveraging its Einstein AI suite to embed predictive analytics and generative capabilities across its platform, catering to increasing enterprise demands for AI-driven solutions. Investors are closely watching how Salesforce navigates the evolving market, balancing AI hype with real-world profitability, while facing competitive pressures and risks like elevated valuations and regulatory scrutiny.

Zimmer Biomet announced it has received FDA 510(k) clearance for expanded reverse shoulder systems, including the Identity® Shoulder System and Comprehensive® Reverse Shoulder Systems. These expansions introduce smaller implant sizes, corresponding surgical tools, and a new Alliance® Humeral Bearing with Vitamin E polyethylene, designed to treat a wider range of patient statures and simplify operating room procedures. The aim is to provide surgeons with more flexibility, improve supply management through shared components, and allow for better bone preservation during shoulder arthroplasty.

Allegion plc, an Irish-domiciled company with significant U.S. operations, specializes in mechanical and electronic security products, including locks, doors, and access controls. Amid rising AI infrastructure buildouts and geopolitical tensions, its focus on securing physical assets through products like cloud-connected access systems positions it as a resilient industrial player. The company's strong presence in North America, steady demand from essential infrastructure like hospitals and schools, and a shift towards electronic solutions make it an appealing investment for U.S. and global English-speaking investors seeking defensive growth with tech-infused elements.

CVS Pharmacy is demonstrating resilience amidst global economic turmoil, leveraging its extensive network and integrated services to act as a stable anchor for health needs in the US. The company's strategic adaptations, including supply chain diversification and Aetna insurance integration, provide it with a competitive edge and make it a defensive play for investors. However, CVS faces challenges such as regulatory scrutiny on PBMs, labor shortages, and cybersecurity threats, which investors should monitor along with upcoming earnings reports and expansion into new services.